Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes After Implementation of a New Oxytocin Protocol for the Prevention of Postpartum Hemorrhage in Non-emergent Cesarean Sections

NCT02722356 is registered in ClinicalTrials.gov with C.R.Darnall Army Medical Center as lead sponsor.

NCT NCT02722356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02722356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes After Implementation of a New Oxytocin Protocol for the Prevention of Postpartum Hemorrhage in Non-emergent Cesarean Sections
Lead sponsor
C.R.Darnall Army Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2016
Completion date
February 28, 2017
Enrollment
64 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse reaction to oxytocin, complications; cesarean section